Bridgebio Pharma, Inc. Common Stock | BBIO

Daily Technical Analysis of Bridgebio Pharma, Inc. Common Stock

Bridgebio Pharma hasn't moved too much today but is slightly down, it has lost -0.44% since yesterday.

Currently BBIO isn't at a clear support/resistance line that seems tradable. Bridgebio Pharma has been drifting up over the last few months, we'll see if it has the energy to keep moving in the right direction. BBIO might find some support at the 39.4 level, buyers might push the price back up from here. But it's not very clear what will happen.

Analyst Ratings for Bridgebio Pharma By Price Target And Rating

The analysts are pretty neutral on BridgeBio Pharma right now, so not much useful information here. The current Analysts Sentiment Score is 1.29. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. Mizuho announced a lowering of their price target to $53.00 from $60.00 on 2024-03-05. On 2024-03-04 HC Wainwright reiterated their rating of Buy and added a price target of $47.00. On 2024-02-23 Citigroup increased their price target by 9.52% to $46.00. BMO Capital Markets initiated a rating of Market Perform on 2024-01-31 and provided a price target of $37.00. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2024-01-22 and they set their price target at $50.00. On 2023-12-08 Wells Fargo & Company initiated their coverage and rated as Overweight and they set their price target at $58.00.JPMorgan Chase & Co. provided a price target decease of -9.52% to $38.00 from $42.00 on 2023-08-17. BTIG Research gave a boost to their price target and moved to $42.00 from $32.00 on 2023-07-18. Raymond James gave a boost to their price target and moved to $46.00 from $29.00 on 2023-07-18. On 2023-07-18 The Goldman Sachs Group increased their price target by 72.41% to $50.00.

Earnings Per Share (EPS) Estimates By Year and Quarter

Short interest for BridgeBio Pharma

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Social Sentiment for BridgeBio Pharma

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.